LONSURF

Product Overview

About LONSURF

LONSURF is a prescription medication containing the active ingredients Tipiracil (Tipiracil Hydrochloride) and Trifluridine. It is used in the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine, oxaliplatin, and irinotecan.

Key Benefits & Uses

• Treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine, oxaliplatin, and irinotecan.
• Combination therapy with other medications to improve treatment outcomes in patients with mCRC.
• Oral administration for convenient dosing and reduced treatment burden.

Active Ingredient & Action

Tipiracil (Tipiracil Hydrochloride) and Trifluridine work together to inhibit thymidylate synthase, a key enzyme involved in DNA synthesis. This action helps to slow down the growth and spread of cancer cells in the body.

Important Notes

LONSURF may cause serious side effects, including neutropenia, thrombocytopenia, and diarrhea. Patients should be closely monitored for these and other potential adverse reactions. It is essential to follow the recommended dosing schedule and consult with a healthcare professional for proper use and guidance.